ORIGINAL_ARTICLE
Late-Life Depression
http://www.jimc.ir/article_118611_80e89049900baec163894c2b79a088ee.pdf
2019-10-01
167
167
Non
Behnam
Shariati
behnamshariatimd@gmail.com
1
Assistant Professor of Psychiatry Department of Psychiatry, School of Medicine, Rasoul-e- Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
1. Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet 2017;389(10076):1323-35. https://pubmed.ncbi.nlm.nih.gov/28236464/
1
2. World Population Ageing: 1950-2050.United Nations Population Division. 2017.
2
3. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1789-858. https://pubmed.ncbi.nlm.nih.gov/30496104/
3
4. World Health Organization. Depression and other common mental disorders: global health estimates. 2017. WHO reference number: WHO/MSD/MER/2017.2
4
5. Sarokhani D, Parvareh M, Hassanpour Dehkordi A, Sayehmiri K, Moghimbeigi A. Prevalence of depression among Iranian elderly: systematic review and meta-analysis. Iranian J Psychiatry 2018;13(1):55-64. https://pubmed.ncbi.nlm.nih.gov/29892318/
5
6. Amerivcan Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. Washington, DC; APA: 2013.
6
7. Small GW. Differential diagnoses and assessment of depression in elderly patients. J Clin Psychiatry 2009;70(12):e47. https://pubmed.ncbi.nlm.nih.gov/20141704/
7
8. Frank C. Pharmacologic treatment of depression in the elderly. Can Fam Physician 2014;60(2):121-6. https://pubmed.ncbi.nlm.nih.gov/24522673/
8
9. Holvast F, Massoudi B, Verhaak PFM. Non-pharmacological treatment for depressed older patients in primary care: A systematic review and meta-analysis. PloS One 2017;12(9):e0184666-e0184666. https://pubmed.ncbi.nlm.nih.gov/28938015/
9
10. Gellis ZD, Kenaley BL, Ten Have T. Integrated telehealth care for chronic illness and depression in geriatric home care patients: the Integrated Telehealth Education and Activation of Mood (I-TEAM) study. J Am Geriatr Soc 2014;62(5):889-95. https://pubmed.ncbi.nlm.nih.gov/24655228/
10
11. Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry 2019;9(1):188-8. https://pubmed.ncbi.nlm.nih.gov/31383842/
11
12. Van Damme A, Declercq T, Lemey L, Tandt H, Petrovic M. Late-life depression: issues for the general practitioner. Int J Gen Med 2018;11:113-20. https://pubmed.ncbi.nlm.nih.gov/29636629/
12
13. Karp JF, Weiner DK, Dew MA, Begley A, Miller MD, Reynolds III CF. Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study. Int J Geriatr Psychiatry 2010;25(6):633-42. https://pubmed.ncbi.nlm.nih.gov/19750557/
13
14. Fortner MR, Brown K, Varia IM, Gersing KR, O’Connor C, Doraiswamy PM. Effect of bupropion SR on the quality of life of elderly depressed patients with comorbid medical disorders. Prim Care Companion J Clin Psychiatry 1999;1(6):174-9. https://pubmed.ncbi.nlm.nih.gov/15014668/
14
15. Perini G, Ramusino MC, Sinforiani E, Bernini S, Petrachi R, Costa A. Cognitive impairment in depression: recent advances and novel treatments. Neuropsychiatr Dis Treat 2019;15:1249-58. https://pubmed.ncbi.nlm.nih.gov/31190831/
15
16. Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol 2009;5:363-89. https://pubmed.ncbi.nlm.nih.gov/19327033/
16
17. Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry 2018;60(Suppl 3):S341-S362. https://pubmed.ncbi.nlm.nih.gov/29535469/
17
18. Geduldig ET, Kellner CH. Electroconvulsive therapy in the elderly: new findings in geriatric depression. Curr Psychiatry Rep 2016;18(4):40. https://pubmed.ncbi.nlm.nih.gov/26909702/
18
ORIGINAL_ARTICLE
Logical Framework Approach for Obesity Management Programs: A Non-Clinical Review
In spite of large resources that have been allocated to manage the obesity, growing obesity trend is still a warning. Some investigators have mentioned global trade liberalization, economic growth and rapid urbanization as factors that may be responsible for this. It seems that lack of using managerial techniques in obesity control programs may be the reason for unsuccessful attempts to stop growing obesity trends. Thus, a systematic review was performed in the field of obesity control programs and management in various databases and a commonly used management approach was explained which seems to be overlooked in the field of obesity management. In the end, an example of an obesity management model was given based on this approach and obesity issue was investigated through a new perspective.
http://www.jimc.ir/article_105339_26876dd055f10b92e8fa0565325efbe6.pdf
2019-10-01
168
173
Logical Framework Approach (LFA)
Management
Obesity
Payam
Hosseinzadeh
payam07@ymail.com
1
Gastrointestinal & Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
AUTHOR
Ali
Mostafavi
mostafavi_a@sina.tums.ac.ir
2
Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Maryam
Chamari
maryamchamari@yahoo.com
3
Faculty of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
1. Unknown-Author. Obesity and overweight. WHO; 2013 [cited 2013 July] http://www.who.int/mediacentre/factsheets/fs311/en/
1
2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011 Feb 12;377(9765):557-67. https://pubmed.ncbi.nlm.nih.gov/21295846/
2
3. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) 2012 Sep;37(6):889-91. https://www.ncbi.nlm.nih.gov/pubmed/22986681/
3
4. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010 Nov;92(5):1257-64. https://www.ncbi.nlm.nih.gov/pubmed/20861173
4
5. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2013 Jan;9(1):13-27. https://pubmed.ncbi.nlm.nih.gov/23165161/
5
6. Keim ME. O2C3: A unified model for emergency operations planning. Am J Disaster Med 2010 May-Jun;5(3):169-79. https://www.ncbi.nlm.nih.gov/pubmed/20701174
6
7. Bell S, Christina A. Applying systemic project management approaches for the UK National Health Service. Systemic Practice and Action Research 2006;19(1):27-43.
7
8. McDonald S, Turner T, Chamberlain C, Lumbiganon P, Thinkhamrop J, Festin MR. Building capacity for evidence generation, synthesis and implementation to improve the care of mothers and babies in South East Asia: methods and design of the SEA-ORCHID Project using a logical framework approach. BMC Med Res Methodol 2010;10:61. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912918/
8
9. Ahmad Dn. Handbook for Logical Framework Analysis: economic planning unit prime ministre’s department; 2010.
9
10. Lobstein T. Commentary: obesity--public health crisis, moral panic or a human rights issue? Int J Epidemiol 2006 Feb;35(1):74-6; discussion 81-2. https://pubmed.ncbi.nlm.nih.gov/16339596
10
11. Taylor-Powell, Henert E. Developing a Logic Model: Teaching and Training Guide. University of Wisconsin-Extension-Cooperative Extension, Program Development and Evaluation Unit; 2008 [cited 2013]; https://sites.aces.edu/group/commhort/vegetable/Vegetable/logic_model_uwex.pdf.
11
12. Ward DS, Vaughn A, Story M. Expert and stakeholder consensus on priorities for obesity prevention research in early care and education settings. Child Obes 2013 Apr;9(2):116-24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621338/
12
13. Stirling A, Lobstein T, Millstone E, PorGrow Research Team. Methodology for obtaining stakeholder assessments of obesity policy options in the PorGrow project. Obes Rev 2007 May;8 (Suppl 2):17-27. https://pubmed.ncbi.nlm.nih.gov/17371304/
13
14. Butchko HH, Petersen BJ. The obesity epidemic: Stakeholder initiatives and cooperation. Nutrition Today 2004;39(6):235-44.
14
ORIGINAL_ARTICLE
The Effectiveness of Psychoeducational Group Intervention on Post-Traumatic Growth: A Randomized Clinical Trial
Background: Breast cancer is a chronic disease that leads to many psychological problems that are involved in treatment and adherence to treatment. The aim of this study was to evaluate the effect of psychoeducational group intervention on psychological factors that help the patients in the treatment process.Methods: In this study, 80 patients were selected by using convenience sampling at Imam Khomeini Hospital. They were randomly allocated either to the intervention group or to the control group. All participants completed the questionnaires of post-traumatic growth, quality of life, subjective well-being, adherence to treatment and social support. The results were analyzed by SPSS-18 software using univariate and multivariate analysis.Results: According to the results, the applied intervention had a significant effect on post-traumatic growth as a primary outcome, and also on subjective well-being and adherence to treatment as secondary outcomes. Conclusion: Psychoeducational group intervention in women with breast cancer can affect the treatment and provide better response to treatment through the improvement of post-traumatic growth, subjective well-being and adherence to treatment.
http://www.jimc.ir/article_105340_3084ca0500fd17478b0fff77a7b12cb4.pdf
2019-10-01
174
183
breast cancer
educational intervention
Post traumatic growth
Randomized clinical trial
Negin
Masoum Abadi
neginmaa2105@gmail.com
1
Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Jamileh
Zarei
zarei.j@iums.ac.ir
2
Department of Health Psychology, Research Center of Spiritual Health, School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Seyede Saleheh
Mortazavi
salehe.mortazavi@gmail.com
3
School of Behavioral Sciences and Mental Health, Tehran Institute of Psychiatry, Iran University of Medical Sciences (IUMS), Tehran, Iran
AUTHOR
Ramesh
Omranipour
omranipour@sina.tums.ac.ir
4
Breast Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
1. Heidarzadeh M, Rassouli M, Brant JM, Mohammadi-Shahbolaghi F, Alavi-Majd H. Dimensions of Posttraumatic Growth in Patients with Cancer: A Mixed-Method Study. Cancer Nurs 2018;41(6):441-9. https://www.ncbi.nlm.nih.gov/pubmed/28806305
1
2. Norouzi H, Rahimian-Boogar I, Talepasand S. Effectiveness of mindfulness-based cognitive therapy on posttraumatic growth,self-management, and functional disability among patients with breast cancer. Nursing Practice Today 2017;4(4):190-202.
2
3. Barthakur MS, Sharma MP, Chaturvedi SK, Manjunath SK. Posttraumatic growth in women survivors of breast cancer. Indian J Palliative Care 2016;22(2):157-62.
3
4. Akbari M, Lotfi Kashani F, Vaziri S. The efficacy of four-factor psychotherapy on increasing sexual self-esteem in breast cancer survivors. Iranian J of Breast Disease. 2017;10(1):48-60.
4
5. Lim SM, Kim HC, Lee S. Psychosocial impact of cancer patients on their family members. Cancer Res Treat 2013;45(3):226. https://www.ncbi.nlm.nih.gov/pubmed/24155682
5
6. Wu X, Kaminga AC, Dai W, Deng J, Wang Z, Pan X, et al. The prevalence of moderate-to-high posttraumatic growth: A systematic review and meta-analysis. J Affect Disord 2019 Jan 15;243:408-15. https://www.ncbi.nlm.nih.gov/pubmed/30268956
6
7. Al-Sulaiman RJ, Bener A, Doodson L, Al Bader SB, Ghuloum S, Lemaux A, et al. Exploring the effectiveness of crisis counseling and psychoeducation in relation to improving mental well-being, quality of life and treatment compliance of breast cancer patients in Qatar. Int J Womens Health 2018;10:285-96. https://www.ncbi.nlm.nih.gov/pubmed/29922098
7
8. Keyes CL, Shapiro AD. Social well-being in the United States: A descriptive epidemiology. How healthy are we? In: Brim OG, Ryff CD, Kessler RC, (Eds.). The John D. and Catherine T. MacArthur foundation series on mental health and development. Studies on successful midlife development. How healthy are we?: A national study of well-being at midlife. USA: University of Chicago Press; 2004.P.350-72.
8
9.Rizalar S, Ozbas A, Akyolcu N, Gungor B. Effect of perceived social support on psychosocial adjustment of Turkish patients with breast cancer. Asian Pac J Cancer Prev 2014;15(8):3429-34. https://www.ncbi.nlm.nih.gov/pubmed/24870734
9
10. Cobb S. Social support as a moderator of life stress. Psychosomatic Medicine 1976;38(5):300-14.
10
11. Flannery Jr RB. Social support and psychological trauma: A methodological review. J Traumatic Stress 1990;3(4):593-611.
11
12. Regehr C, Hill J, Knott T, Sault B. Social support, self‐efficacy and trauma in new recruits and experienced firefighters. Stress and Health 2003;19(4):189-93.
12
13. Prati G, Pietrantoni L. Optimism, social support, and coping strategies as factors contributing to posttraumatic growth: A meta-analysis. J Loss and Trauma 2009;14(5):364-88.
13
14. Shorey S, Chan SWC, Chong YS, He HG. A randomized controlled trial of the effectiveness of a postnatal psychoeducation program on self‐efficacy, social support and postnatal depression among primiparas. J Adv Nurs 2015;71(6):1260-73. https://www.ncbi.nlm.nih.gov/pubmed/25496615
14
15. Brand EF, Lakey B, Berman S. A preventive, psychoeducational approach to increase perceived social support. Am J Community Psychol 1995;23(1):117-35. https://www.ncbi.nlm.nih.gov/pubmed/7572825
15
16. Scrignaro M, Barni S, Magrin ME. The combined contribution of social support and coping strategies in predicting post‐traumatic growth: a longitudinal study on cancer patients. Psycho‐Oncology 2011;20(8):823-31. https://pubmed.ncbi.nlm.nih.gov/20878872/
16
17. Schroevers MJ, Helgeson VS, Sanderman R, Ranchor AV. Type of social support matters for prediction of posttraumatic growth among cancer survivors. Psycho‐Oncology 2010;19(1):46-53. http://pubmed.ncbi.nlm.nih.gov/19253269/
17
18. Bozo Ö, Gündoğdu E, Büyükaşik-Çolak C. The moderating role of different sources of perceived social support on the dispositional optimism-posttraumatic growth relationship in postoperative breast cancer patients. J Health Psychol 2009;14(7):1009-20. https://pubmed.ncbi.nlm.nih.gov/19786527/
18
19. Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: Measuring the positive legacy of trauma. J Trauma Stress 1996;9(3):455-71. . https://pubmed.ncbi.nlm.nih.gov/8827649/
19
20. Matsuda A, Yamaoka K, Tango T, Matsuda T, Nishimoto H. Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res 2014;23(1):21-30. https://pubmed.ncbi.nlm.nih.gov/23881515/
20
21. Diener E. Subjective well-being. Psychological Bulletin 1984;95(3):542-75.
21
22. Marashi T, Taherianfar Z, Etemad K, Rakhsha A. [Survey of quality of life of patients with breast cancer among women at Shahid Beheshti University of Medical science and Health service 2017]. Journal Health in the Field 2018;6(1):1-8. Persian.
22
23. Esfandiar B, Kazemi M, Amanpour E, Tizfahm T. The relationship between religion, spiritual, health, hope, and quality of life in cancer patients. BCCR 2014;6(4):28-36.
23
24.Shobeiri F, Nikravesh A, Masoumi SZ, Heidari Moghaddam R, Karami M, Badafreh M. [The effect of exercise counseling on functional measures of quality of life in women with breast cancer]. J Education and Community Health 2015;2(1):1-9. Persian.
24
25-Moharamzad Y, Saadat H, Shahraki BN, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci 2015;7(4):173. https://pubmed.ncbi.nlm.nih.gov/25946926/
25
26. Fawzy FI, Fawzy NW. A structured psychoeducational intervention for cancer patients. Gen Hosp Psychiatry 1994 May;16(3):149-92. https://pubmed.ncbi.nlm.nih.gov/8063085/
26
27. Aggarwal B, Liao M, Allegrante JP, Mosca L. Low social support level is associated with non-adherence to diet at one year in the Family Intervention Trial for Heart Health (FIT Heart). J Nutrition Education and Behavior 2010;42(6):380-8.
27
28. Shorey S, Chan SWC, Chong YS, He HG. A randomized controlled trial of the effectiveness of a postnatal psychoeducation program on self‐efficacy, social support and postnatal depression among primiparas. J Adv Nurs 2015;71(6):1260-73. https://pubmed.ncbi.nlm.nih.gov/25496615/
28
29.Hashemian K, Pourshahriari MS, Bani Jamali MAS, Golestanie Bakht T. Investigating the relationship between demographic characteristics and subjective biodiversity and happiness in Tehran population. J Educational Psychology Studies 2007;3(3):139-63.
29
30. Pat‐Horenczyk R, Perry S, Hamama‐Raz Y, Ziv Y, Schramm‐Yavin S, Stemmer SM. Posttraumatic growth in breast cancer survivors: Constructive and illusory aspects. J Trauma Stress 2015;28(3):214-22. https://pubmed.ncbi.nlm.nih.gov/26013468/
30
31. Garlan RW, Butler LD, Siegel ERA, Spiegel D. Perceived benefits and psychosocial outcomes of a brief existential family intervention for cancer patients/survivors. Omega-Journal of Death and Dying 2011;62(3):243-68. https://pubmed.ncbi.nlm.nih.gov/21495534/
31
32. Lelorain S, Bonnaud-Antignac A, Florin A. Long term posttraumatic growth after breast cancer: prevalence, predictors, and relationships with psychological health. J Clin Psychol Med Settings 2010;17(1):14-22. https://pubmed.ncbi.nlm.nih.gov/20082122/
32
33. Matsuda A, Yamaoka K, Tango T, Matsuda T, Nishimoto H. Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res 2014;23(1):21-30. https://pubmed.ncbi.nlm.nih.gov/23881515/
33
34. Dow Meneses K, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA, editors. Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum 2007;34(5):1007‐16. https://pubmed.ncbi.nlm.nih.gov/17878129/
34
35. Ram S, Narayanasamy R, Barua A. Effectiveness of group psycho-education on well-being and depression among breast cancer survivors of Melaka, Malaysia. Indian J Palliat Care 2013;19(1):34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680837/
35
36. Bloom JR, Stewart SL, Johnston M, Banks P, Fobair P. Sources of support and the physical and mental well-being of young women with breast cancer. Soc Sci Med 2001;53(11):1513-24. https://pubmed.ncbi.nlm.nih.gov/11710426/
36
37. Jeffries SA, Robinson JW, Craighead PS, Keats MR. An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 2006;65(2):404-11. https://pubmed.ncbi.nlm.nih.gov/16542794/
37
38. Myers RE, Chodak GW, Wolf TA, Burgh DY, McGrory GT, Marcus SM, et al. Adherence by African American men to prostate cancer education and early detection. Cancer 1999;86(1):88-104. https://pubmed.ncbi.nlm.nih.gov/10391568/
38
39. Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res 2013;11(2):54-65. https://pubmed.ncbi.nlm.nih.gov/23580788/
39
40. Baglama B, Atak IE. Posttraumatic growth and related factors among postoperative breast cancer patients. Procedia-Social and Behavioral Sciences 2015;190:448-54.
40
41. Sears SR, Stanton AL, Danoff-Burg S. The yellow brick road and the emerald city: benefit finding, positive reappraisal coping, and posttraumatic growth in women with early-stage breast cancer. Health Psychol 2003;22(5):487-97. https://pubmed.ncbi.nlm.nih.gov/14570532/
41
42. Ginzburg K, Ein-Dor T. Posttraumatic stress syndromes and health-related quality of life following myocardial infarction: 8-year follow-up. Gen Hosp Psychiatry 2011;33(6):565-71.
42
ORIGINAL_ARTICLE
The Possible Association Between Circadian Rhythm Chronotypes and Unhealthy Metabolic Phenotypes in Overweight/ Obese Women
Background: Circadian rhythm affects individual body function and health. Although it can regulate many biological processes in the body such as hormone release and eating habits, little is known about the relationship between circadian rhythm and metabolic disorders. Therefore, the purpose of the present research was to examine the association between Circadian Rhythm Chronotypes (CRC) and metabolic health status components, in patients with overweight and obesity.Methods: A cross-sectional study was conducted at the healthcare centres of Tehran. Patients with Overweight and Obesity (OW/OB) (n 374) aged 18 to 56 years were rectruited. All participants were assessed for metabolic health status components based on Karelis criteria (HDL, LDL, TG, hs-CRP and HOMA-IR). Morningness - Eveningness Questionnaire (MEQ) was used for chronotype categorizing. Also, bioelectrical impedance analysis (BIA) was applied to evaluate body composition. Regression model in crude and adjusted model was used to assess the relation between CRC and metabolic status.Results: The differences in CRC were not significant in terms of Karelis criteria components except hs-CRP (p=0.02). Results had shown that the trend of hs-CRP tends to decrease from eveningness chronotype to morningness chronotype and it significantly increased in crude model (p=0.007) and adjusted model (p=0.03). In addition, hs-CRP had decreased significantly in morningness chronotype in comparison with eveningness chronotype in crude model [OR (95% CI): 0.28 (0.10 to 0.79), p=0.01].Conclusion: This study indicated an association between hs-CRP and CRC in women patients with overweight and obesity, which indicates that inflammation may have a relation to the CRC and metabolic status.
http://www.jimc.ir/article_105348_54d900142cfb10b84644bc22068c85f6.pdf
2019-10-01
184
191
Circadian rhythm chronotypes
Obesity
Unhealthy metabolic status
Moein
Askarpour
1
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
yarizadeh
yarizadeh
habib.yari72@yahoo.com
2
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Niloofar
Rasaei
3
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Negin
Badrooj
4
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Kurosh
Djafarian
kdjafarian@tums.ac.ir
5
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Khadijeh
Mirzaei
mirzaei_kh@tums.ac.ir
6
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obesity 2008;32:1431-7. https://pubmed.ncbi.nlm.nih.gov/18607383/
1
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-9. https://pubmed.ncbi.nlm.nih.gov/12503980/
2
3. Jung CH, Lee WJ, Song KH. Metabolically healthy obesity: a friend or foe? Korean J Intern Med 2017;32(4):611-21. https://pubmed.ncbi.nlm.nih.gov/28602062/
3
4. Denis GV, Obin MS. ‘Metabolically healthy obesity’: origins and implications. Mol Aspects Med 2013;34:59-70. https://pubmed.ncbi.nlm.nih.gov/23068072/
4
5. Toth LA. Sleep, sleep deprivation and infectious disease: studies in animals. Advances in neuroimmunology 1995;5(1):79-92. https://pubmed.ncbi.nlm.nih.gov/7795895/
5
6. Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 2013;98(10):E1610-9. https://pubmed.ncbi.nlm.nih.gov/23979951/
6
7. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90(7):4145-50. https://pubmed.ncbi.nlm.nih.gov/15855252/
7
8. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299(3):E506-15. https://pubmed.ncbi.nlm.nih.gov/20570822/
8
9. Yoshida K, Hashimoto T, Sakai Y, Hashiramoto A. Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis. J Immunol Res 2014;2014:6. https://pubmed.ncbi.nlm.nih.gov/24901009/
9
10. Sokolove GP. Localization of the optic lobe arcadian pacemaker with microlesions. Brain Res 1975;87:13-21. https://pubmed.ncbi.nlm.nih.gov/1120252/
10
11. Zee PC, Attarian H, Videnovic A. Circadian rhythm abnormalities. Continuum 2013;19:132-47. https://pubmed.ncbi.nlm.nih.gov/23385698/
11
12. Hand LE, Hopwood TW, Dickson SH, Walker AL, Loudon AS, Ray DW, et al. The circadian clock regulates inflammatory arthritis. The FASEB J 2016;30(11):3759-70. https://pubmed.ncbi.nlm.nih.gov/27488122/
12
13. Asher G, Sassone-Corsi P. Time for food: The intimate interplay between nutrition, metabolism, and the circadian clock. Cell 2015;161(1):84-92. https://pubmed.ncbi.nlm.nih.gov/25815987/
13
14. Vasheghani-Farahani A, Tahmasbi M, Asheri H, Ashraf H, Nedjat S, Kordi R. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med 2011;2(2):106-16. https://pubmed.ncbi.nlm.nih.gov/22375226/
14
15. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008;34(2):183-4. https://pubmed.ncbi.nlm.nih.gov/18329310/
15
16. Rahafar A, Randler C, Díaz-Morales J, Kasaeian A, Heidari Z. Cross-cultural validity of Morningness-Eveningness Stability Scale improved (MESSi) in Iran, Spain and Germany. Chronobiol Int 2017;34(2):1-7. https://pubmed.ncbi.nlm.nih.gov/28055262/
16
17. Shahid A, Wilkinson K, Marcu S, Shapiro CM. Morningness-Eveningness Questionnaire. In: Shahid A, Wilkinson K, Marcu S, Shapiro CM, eds. STOP, THAT and One Hundred Other Sleep Scales. New York, NY: Springer New York; 2012.p.231-4.
17
18. Merikanto I, Lahti T, Puolijoki H, Vanhala M, Peltonen M, Laatikainen T, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int 2013;30(4):470-7. https://pubmed.ncbi.nlm.nih.gov/23281716/
18
19. Yu JH, Yun C-H, Ahn JH, Suh S, Cho HJ, Lee SK, et al. Evening chronotype is associated with metabolic disorders and body composition in middle-aged adults. J Clin Endocrinol Metab 2015;100:1494-502. https://pubmed.ncbi.nlm.nih.gov/25831477/
19
20. Baron KG, Reid KJ. Circadian Misalignment and Health. Int Rev Psychiatry 2014;26(2):139-54. https://pubmed.ncbi.nlm.nih.gov/24892891/
20
21. Merikanto I, Lahti T, Puolijoki H, Vanhala M, Peltonen M, Laatikainen T, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int 2013;30(4):470-7. https://pubmed.ncbi.nlm.nih.gov/23281716/
21
22. Wefers J, van Moorsel D, Hansen J, Connell NJ, Havekes B, Hoeks J, et al. Circadian misalignment induces fatty acid metabolism gene profiles and compromises insulin sensitivity in human skeletal muscle. Proc Natl Acad Sci USA 2018;115(30):7789-94. https://pubmed.ncbi.nlm.nih.gov/29987027/
22
23. Esquirol Y, Bongard V, Mabile L, Jonnier B, Soulat JM, Perret B. Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms. Chronobiol Int 2009;26(3):544-59. https://pubmed.ncbi.nlm.nih.gov/19360495/
23
24. De Bacquer D, Van Risseghem M, Clays E, Kittel F, De Backer G, Braeckman L. Rotating shift work and the metabolic syndrome: a prospective study. Int J Epidemiol 2009;38:848-54. https://pubmed.ncbi.nlm.nih.gov/19129266/
24
25. Ghiasvand M, Heshmat R, Golpira R, Haghpanah V, Soleimani A, Shoushtarizadeh P, et al. Shift working and risk of lipid disorders: a cross-sectional study. Lipids Health Dis 2006;5:9. https://pubmed.ncbi.nlm.nih.gov/16606444/
25
26. Knutsson A. Relationships between serum triglycerides and gamma-glutamyltransferase among shift and day workers. J Intern Med 1989;226(5):337-9. https://pubmed.ncbi.nlm.nih.gov/2572667/
26
27. Di Lorenzo L, De Pergola G, Zocchetti C, L’Abbate N, Basso A, Pannacciulli N, et al. Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Int J Obesity 2003;27:1353-8. https://pubmed.ncbi.nlm.nih.gov/14574346/
27
28. Knutson A, Andersson H, Berglund U. Serum lipoproteins in day and shift workers: a prospective study. Br J Ind Med 1990;47(2):132-4. https://pubmed.ncbi.nlm.nih.gov/2310717/
28
29. Gonnissen HKJ, Mazuy C, Rutters F, Martens EAP, Adam TC, Westerterp-Plantenga MS. Sleep architecture when sleeping at an unusual circadian time and associations with insulin sensitivity. PLoS One 2013;8(8):e72877. https://pubmed.ncbi.nlm.nih.gov/23951335/
29
30. Sookoian S, Gemma C, Fernandez Gianotti T, Burgueno A, Alvarez A, Gonzalez CD, et al. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. J Intern Med 2007;261:285-92. https://pubmed.ncbi.nlm.nih.gov/17305651/
30
31.Puttonen S, Viitasalo K, Harma M. Effect of shiftwork on systemic markers of inflammation. Chronobiol Int 2011;28:528-35. https://pubmed.ncbi.nlm.nih.gov/21797781/
31
32. Morris CJ, Purvis TE, Mistretta J, Hu K, Scheer FAJL. Circadian misalignment increases C-reactive protein and blood pressure in chronic shift workers. J Biol Rhythms 2017;32(2):154-64. https://pubmed.ncbi.nlm.nih.gov/28347188/
32
33. Kato M, Phillips BG, Sigurdsson G, Narkiewicz K, Pesek CA, Somers VK. Effects of sleep deprivation on neural circulatory control. Hypertension 2000;35:1173-5. https://pubmed.ncbi.nlm.nih.gov/10818083/
33
34. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997;158(9):4454-64. https://pubmed.ncbi.nlm.nih.gov/9127011/
34
35. Morris CJ, Purvis TE, Hu K, Scheer FA. Circadian misalignment increases cardiovascular disease risk factors in humans. Proc Natl Acad Sci USA 2016;113(10):E1402-11. https://pubmed.ncbi.nlm.nih.gov/26858430/
35
36. Leproult R, Holmback U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014;63(6):1860-9. https://pubmed.ncbi.nlm.nih.gov/24458353/
36
37. Wright KP Jr., Drake AL, Frey DJ, Fleshner M, Desouza CA, Gronfier C, et al. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain, Behav Immun 2015;47:24-34. https://pubmed.ncbi.nlm.nih.gov/25640603/
37
38. Castanon-Cervantes O, Wu M, Ehlen JC, Paul K, Gamble KL, Johnson RL, et al. Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 2010;185(10):5796-805. https://pubmed.ncbi.nlm.nih.gov/20944004/
38
39. Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED, Volk HD, et al. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci USA 2009;106(50):21407-12. https://pubmed.ncbi.nlm.nih.gov/19955445/
39
40. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002;2(2):167-79. https://pubmed.ncbi.nlm.nih.gov/11899099/
40
41. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005;27:189-200. https://pubmed.ncbi.nlm.nih.gov/16217132/
41
42. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002;10 Suppl 2:97-104. https://pubmed.ncbi.nlm.nih.gov/12490658/
42
43. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288(5):H2031-41. https://pubmed.ncbi.nlm.nih.gov/15653761/
43
ORIGINAL_ARTICLE
Chromosomal Patterns, Demographics, Clinical Features, and Karyotype-Phenotype Correlation in Patients with Turner Syndrome
Background: Turner Syndrome (TS) is caused by the complete or partial absence/abnormality of the second X chromosome in some or all cells.The purpose of this study was to assess the correlation between clinical presentation and karyotype variations of X chromosome in TS.Methods: In a retrospective case-series using medical records (2001-17) for our pediatric-endocrinology TS patients, additional data were collected using a questionnaire and detailed physical examination, including demographics, initial presentation, clinical characteristics at diagnosis, height, puberty stage, cardiovascular and renal malformations, uterus and ovary status, and hormonal profile. Three patient-groups of monosomy X (45,X) cases, 45,X/46,XX or 45,X/46,XY mosaicism cases, and cases with other aberrations of X chromosome were compared in this study. Results: In 57 TS patients (Age range 6 months to 25 years (Mean 11.85±5.1 yrs.)), 3.5% were diagnosed in infancy because of lymphedema and congenital heart disease. Short stature was the initial presentation in 78.9%. On presentation, 94.7% were short. Other referrals included cases with primary amenorrhea (12%), delayed puberty (5.3%), leg edema (1.8%) and congenital heart disease (1.8%). Mean height standard deviation score was 3.7±1.8 SD below mean for age and sex. Overall, 50.9% of cases had all clinical features consistent with TS and 21.1% had no symptoms of TS other than short stature. Of 39 patients in pubertal age, 31.6% had degrees of breast maturity. Most of them had X structural abnormalities (40.3%). However, 33.3% had classic TS. Still, 5.3% had Y-chromosome material. Among three karyotype groups, clinical symptoms and phenotypes were not significantly different. Conclusion: The study found no correlation between the clinical presentation and karyotype variations of TS.
http://www.jimc.ir/article_105341_ab78c1871f3811285bf200a4277a5772.pdf
2019-10-01
192
200
Amenorrhea
chromosomes
Gonadal dysgenesis
karyotype
Turner syndrome
zahra
razavi
razavizahra@yahoo.com.au
1
Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran
LEAD_AUTHOR
Seyed-Mahmoud
Tabatabaei
smt@iaut.ac.ir
2
Department of Physiology, Genetics Tabriz Branch, Islamic Azad University, Tabriz branch, Tabriz, Iran
AUTHOR
Nasim
Ansari
n.ansari4171@gmail.com
3
Clinical Research Center of Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
AUTHOR
Mojgan
Shahbazi
m_shahbazi123@yahoo.com
4
Clinical Research Center of Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
AUTHOR
1. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010;95(4):1487-95. https://pubmed.ncbi.nlm.nih.gov/20375216/
1
2. Darendeliler F, Yeşilkaya E1, Bereket A, Baş F, Bundak R, Sarı E, et al. Growth curves for Turkish girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group. J Clin Res Pediatr Endocrinol 2015;7(3):183-91. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677552/
2
3. Razavi Z, Momtaz HE. Balanced reciprocal translocation t(X;1) in a girl with tall stature and primary amenorrhea. Iran J Med Sci 2017;42(2):210-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366371/
3
4. Nakamura T, Tsuburai T, Tokinaga A, Nakajima I, Kitayama R, Imai Y, et al. Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocr J 2015;62(11):965-70. https://pubmed.ncbi.nlm.nih.gov/26289838/
4
5. Oliveira CS, Alves C. 1 The role of the SHOX gene in the pathophysiology of Turner syndrome. Endocrinol Nutr 2011;58:433-42. https://pubmed.ncbi.nlm.nih.gov/21925981/
5
6. Gonzalez L, Witchel SF. The patient with Turner syndrome: puberty and medical management concerns. Fertil Steril 2012;98(4):780-6. https://pubmed.ncbi.nlm.nih.gov/22884020/
6
7. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner Syndrome. J Clin Endocrinol Metab 2006;91(10):3897-902. https://pubmed.ncbi.nlm.nih.gov/16849410/
7
8. Moka R, Sreelakshmi K, Gopinath PM, Satyamoorthy K. Cytogenetic evaluation of patients with clinical spectrum of Turner syndrome. J Hum Reprod Sci 2013;6(2):129-32. https://pubmed.ncbi.nlm.nih.gov/24082654/
8
9. Bharath R, Unnikrishnan AG, Thampy MV, Anilkumar A, Nisha B, Praveen VP, et al. Turner Syndrome and its variants. Indian J Pediatr 2010;77(2):193-5. https://pubmed.ncbi.nlm.nih.gov/20012804/
9
10. Poprawski K, Michalski M, Ławniczak M, Łacka K. Cardiovascular abnormalities in patients with Turner syndrome according to karyotype: own experience and literature review. Pol Arch Med Wewn 2009;119(7-8):453-60. https://www.ncbi.nlm.nih.gov/pubmed/19776685
10
11. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 1999;84(12):4613-21. https://pubmed.ncbi.nlm.nih.gov/10599728/
11
12. Carvalho AB, Lemos-Marini SHV, Guerra-Junior G, Maciel-Guerra AT. Clinical and cytogenetic features of 516 patients with suspected Turner syndrome - a single-center experience. J Pediatr Endocrinol Metab 2018;31(2):167-73. https://pubmed.ncbi.nlm.nih.gov/29303780/
12
13. Saikia UK, Sarma D, Yadav Y. Delayed presentation of Turner Syndrome: Challenge to optimal management. J Hum Reprod Sci 2017;10(4):297-301. https://pubmed.ncbi.nlm.nih.gov/29430158/
13
14. Reddy Danda VS, Sreedevi P, Arun G, Rao PS. Growth hormone treatment in Turner’s syndrome: A real world experience. Indian J Endocrinol Metab 2017;21(3):378-381. https://pubmed.ncbi.nlm.nih.gov/28553590/
14
15. Zheng J, Liu Z, Xia P, Lai Y, Wei Y, Liu Y, et al. [Clinical manifestation and cytogenetic analysis of 607 patients with Turner syndrome]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2017;34(1):61-4. Chinese. https://pubmed.ncbi.nlm.nih.gov/28186596/
15
16. Elleuch M, Mnif Feki M, Kammoun M, Charfi N, Rekik N, Bouraoui A. Descriptive analyses of Turner syndrome: 49 cases in Tunisia. Ann Endocrinol (Paris) 2010;71(2):111-6. https://pubmed.ncbi.nlm.nih.gov/20153455/
16
17. Alves M, Bastos M, Almeida Santos T, Carrilho F. [Gonadal function in Turner syndrome]. Acta Med Port 2013;26(6):655-63. Portuguese. https://pubmed.ncbi.nlm.nih.gov/24388251/
17
18. Aso K, Koto S, Higuchi A, Ariyasu D, Izawa M, Miyamoto Igaki J, et al. Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocr J 2010;57(10):909-13. https://pubmed.ncbi.nlm.nih.gov/20798475/
18
19. Chang P, Tsau YK, Tsai WY, Tsai WS, Hou JW, Hsiao PH, et al. Renal malformations in children with Turner’s syndrome. J Formos Med Assoc 2000;99(10):796-8. https://pubmed.ncbi.nlm.nih.gov/11061079/
19
20. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-9. https://pubmed.ncbi.nlm.nih.gov/11443168/
20
21. Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med 2004;351:1227-38. https://pubmed.ncbi.nlm.nih.gov/15371580/
21
22. Castronovo C, Rossetti R, Rusconi D, Recalcati MP, Cacciatore C, Beccaria E, et al. Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome. Hum Reprod 2014;29(2):368-79. https://pubmed.ncbi.nlm.nih.gov/24324027/
22
23. Mohamed SOO, Elkhidir IHE, Abuzied AIH, Noureddin AAMH, Ibrahim GAA, Mahmoud AAA. Prevalence of autoimmune thyroid diseases among the Turner Syndrome patients: meta-analysis of cross sectional studies. BMC Res Notes 2018;11(1):842. https://pubmed.ncbi.nlm.nih.gov/30486859/
23
24. Kammoun I, Chaabouni M, Trabelsi M, Ouertani I, Kraoua L, Chelly I, et al. Genetic analysis of Turner syndrome: 89 cases in Tunisia. Ann Endocrinol (Paris) 2008;69(5) 440-5. https://pubmed.ncbi.nlm.nih.gov/18541220/
24
25. Wu HH, Li H. Karyotype classification, clinical manifestations and outcome in 124 Turner syndrome patients in China. Ann Endocrinol (Paris) 2019;80(1):10-15. https://pubmed.ncbi.nlm.nih.gov/29580553/
25
26. Al Alwan I, Khadora M, Amir I, Nasrat G, Omair A, Brown L, et al. Turner Syndrome Genotype and phenotype and their effect on presenting features and timing of Diagnosis. Int J Health Sci (Qassim) 2014;8(2):195-202. https://pubmed.ncbi.nlm.nih.gov/25246887/
26
27. Liang Y, Cheng J, Cai YN, Wei XP. [Karyotypes and pelvic ultrasonography in children with Turner syndrome]. Zhongguo Dang Dai Er Ke Za Zhi 2008;10(2):158-60. Chinese. https://pubmed.ncbi.nlm.nih.gov/18433536/
27
28. Rojek A, Kwasiuk K, Obara-Moszyńska M, Kolesińska Z, Niedziela M. [Y chromosome in Turner syndrome]. Pediatr Endocrinol Diabetes Metab 2017;23(1):37-41. https://pubmed.ncbi.nlm.nih.gov/29073306/
28
29. Oliveira RM, Verreschi IT, Lipay MV, Eça LP, Guedes AD, Bianco B. Y chromosome in Turner syndrome: review of the literature. Sao Paulo Med J 2009;127(6):373-8. https://pubmed.ncbi.nlm.nih.gov/20512293/
29
ORIGINAL_ARTICLE
Redo Percutaneous Mitral Valvuloplasty (Redo PMV) in Patients With Recurrent Mitral Valve Stenosis: Immediate and Early Outcomes
Background: Symptomatic recurrent mitral valve stenosis develops in some patients after Percutaneous Mitral Valvuloplasty (PMV). This study assessed the immediate and early outcomes of redo PMV in patients with recurrent mitral valve stenosis after prior PMV.Methods: Fifty-four patients (40 women and 14 men, mean age of 38±8.2 years) underwent a redo (second) PMV for symptomatic restenosis of mitral valve [with Mitral Valve Area (MVA) < 1.5 cm2]. Redo PMV was performed at 5.8±1.2 years after the initial PMV.Results: In this study, 48 hours after the procedure, there was a substantial increase in MVA by 2-dimensional Echocardiography (GE, Vivid 7) from 1.0±0.2 to 2.2±0.4 cm2 (p<0.001) and a decrease in mean left atrial pressure from 27 ± 5 to 15 ± 4 mmHg (p<0.001) and in mean transmitral valve gradient from 15±4 to 2±1 mmHg (p Conclusion: Redo PMV can be performed successfully in patients with recurrent mitral valve stenosis following previous percutaneous valvuloplasty.
http://www.jimc.ir/article_105342_79b465c36e8d8f06147e2db779f5e28e.pdf
2019-10-01
201
208
echocardiography
Heart valve diseases
MITRAL VALVE
Mitral valve stenosis
Massoud
Ghasemi
1
Research Center of Endovascular Intervention, Department of Interventional Cardiology, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Maryam
Mehrpouya
maryammehrpooya1@gmail.com
2
Department of Interventional Cardiology, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Farshad
Ghasemi
3
University of Toronto, Mount Sinai Hospital,700 University Avenue , 3rd floor, Room 3-522,Toronto, ON, M5G Canada
AUTHOR
Mohammad Reza
Movahed
4
University of Arizona,Tucson, Arizona, USA
AUTHOR
Babak
Sattartabar
5
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
1. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87(3):394-402. https://pubmed.ncbi.nlm.nih.gov/6700245/
1
2. Palacios IF, Silva GV. Percutaneous mitral balloon valvuloplasty: surviving the test of time. Revista Brasileira de Cardiologia Invasiva 2012;20(3):237-8.
2
3. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA 1993;270(14):1731-6. https://pubmed.ncbi.nlm.nih.gov/8411505/
3
4. Vavuranakis M, Stratos C, Kalogeras K, Aggeli C, Tsiachris D, Vaina S, et al. An alternative method of percutaneous mitral valvuloplasty. Matching electrophysiology with interventional cardiology techniques. Int J Cardiol 2015;191:294-5. https://www.ncbi.nlm.nih.gov/pubmed/25984897/
4
5. Palacios IF, Tuzcu ME, Weyman AE, Newell JB, Block PC. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation 1995;91(3):671-6. https://pubmed.ncbi.nlm.nih.gov/7828292/
5
6. Hernandez R, Banuelos C, Alfonso F, Goicolea J, Fernández-Ortiz A, Escaned J, et al. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation 1999;99(12):1580-6. https://pubmed.ncbi.nlm.nih.gov/10096934/
6
7. Rifaie O, Ismail M, Helmy M, El-Bialy M, Nammas W. Redo percutaneous mitral valvuloplasty for mitral restenosis: a comparison with first procedure for de novo mitral stenosis. Kardiol Pol (Polish Heart Journal) 2011;69(2):125-31. https://pubmed.ncbi.nlm.nih.gov/21332049/
7
8. Rifaie O, Ismail M, Helmy M, El-Bialy M, Nammas W. Redo percutaneous mitral valvuloplasty for mitral restenosis: a comparison with first procedure for de novo mitral stenosis. Kardiologia polska. 2010;69(2):125-31.
8
9. Iung B, Garbarz E, Michaud P, Fondard O, Helou S, Kamblock J, et al. Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. European Heart J 2000;21(20):1683-9. https://pubmed.ncbi.nlm.nih.gov/11032695/
9
10. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J American College of Cardiology 2017. Circulation 2017 Jun 20;135(25):e1159-e1195. https://pubmed.ncbi.nlm.nih.gov/28298458/
10
11. Wilkins G, Weyman AE, Abascal V, Block P, Palacios I. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60(4):299-308. https://pubmed.ncbi.nlm.nih.gov/3190958/
11
12. Nobuyoshi M, Arita T, Shirai S-i, Hamasaki N, Yokoi H, Iwabuchi M, et al. Percutaneous balloon mitral valvuloplasty: a review. Circulation 2009;119(8):e211-e9. https://pubmed.ncbi.nlm.nih.gov/19106383/
12
13. Tastan A, Ozturk A, Senarslan O, Ozel E, Uyar S, Ozcan EE, et al. Comparison of two different techniques for balloon sizing in percutaneous mitral balloon valvuloplasty: which is preferable? Cardiovascular J Africa 2016;27(3):147. https://pubmed.ncbi.nlm.nih.gov/26813869/
13
14. Hung JS. Atrial septal puncture technique in percutaneous transvenous mitral commissurotomy: mitral valvuloplasty using the Inoue balloon catheter technique. Catheterization and Cardiovascular Diagnosis 1992;26(4):275-84. https://pubmed.ncbi.nlm.nih.gov/1394414/
14
15. Babaliaros VC, Green JT, Lerakis S, Lloyd M, Block PC. Emerging applications for transseptal left heart catheterization: old techniques for new procedures. J Am Coll Cardiol 2008;51(22):2116-22. https://pubmed.ncbi.nlm.nih.gov/18510957/
15
16. Naik N. How to perform transeptal puncture. Indian Heart J 2015;67(1):70-6. https://pubmed.ncbi.nlm.nih.gov/25820057/
16
17. Ben-Farhat M, Betbout F, Gamra H, Maatouk F, Ben-Hamda K, Abdellaoui M, et al. Predictors of long-term event-free survival and of freedom from restenosis after percutaneous balloon mitral commissurotomy. Am Heart J 2001;142(6):1072-9. https://pubmed.ncbi.nlm.nih.gov/11717614/
17
18. Iung B, Garbarz E, Doutrelant L, Berdah P, Michaud P, Farah B, et al. Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. American J Cardio 2000;85(11):1308-14. https://pubmed.ncbi.nlm.nih.gov/10831945/
18
19. Ali L, Asghar N, Riaz R, Hussain M. Percutaneous transmitral commissurotomy (PTMC); procedural success and immediate results, a tertiary care hospital experience from develping country. Professional Medical J 2016;23(1).
19
20. Dean LS. Complications and mortality of percutaneous balloon mitral commissurotomy. Circulation 1992;85(6):2014-24. https://pubmed.ncbi.nlm.nih.gov/1591821/
20
21. Bouleti C, Iung B, Brochet E, Messika-Zeitoun D, Himbert D, Garbarz E, et al. The impact of the presence and extent of valve calcification on long-term results of percutaneous mitral commissurotomy. Archives of Cardiovascular Diseases Supplements 2013;5(1).
21
22. Esteves WAM, Lodi-Junqueira L, Soares JR, Athayde GRSA, Goebel GA, Carvalho LA, et al. Impact of percutaneous mitral valvuloplasty on left ventricular function in patients with mitral stenosis assessed by 3D echocardiography. Int J Cardiol 2017 Dec 1;248:280-5. https://www.ncbi.nlm.nih.gov/pubmed/28712559
22
23. Harken DE, Black H, Taylor WJ, Thrower WB, Ellis LB. Reoperation for mitral stenosis. Circulation 1961;23(1):7-12. https://pubmed.ncbi.nlm.nih.gov/13711582/
23
24. Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty. Circulation 1973;48(2):357-64. https://pubmed.ncbi.nlm.nih.gov/4726216/
24
25. John S, Bashi V, Jairaj P, Muralidharan S, Ravikumar E, Rajarajeswari T, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation 1983;68(5):891-6. https://pubmed.ncbi.nlm.nih.gov/6616794/
25
26. Palacios IF, Block PC, Wilkins GT, Weyman AE. Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation 1989;79(3):573-9. https://pubmed.ncbi.nlm.nih.gov/2917388/
26
27. Pan M, Medina A, de Lezo J, Hernández E, Romero M, Pavlovic D, et al. Factors determining late success after mitral balloon valvulotomy. Am J Cardiol 1993;71(13):1181-5. https://pubmed.ncbi.nlm.nih.gov/8480644/
27
28. Block PC, Palacios IF, Block EH, Tuzcu EM, Griffin B. Late (two-year) follow-up after percutaneous balloon mitral valvotomy. Am J Cardiol 1992;69(5):537-41. https://pubmed.ncbi.nlm.nih.gov/1736620/
28
29. Shavelle DM, Otto CM, Tavel ME. Recurrent mitral stenosis: Problems of management. CHEST J 2001;119(3):958-60. https://pubmed.ncbi.nlm.nih.gov/11243982/
29
30. Dean LS, Mickel M, Bonan R, Holmes DR, O’Neill WW, Palacios IF, et al. Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy A report from then national heart, lung, and blood institute balloon valvuloplasty registry. J American College of Cardiology 1996;28(6):1452-7. https://pubmed.ncbi.nlm.nih.gov/8917257/
30
31. Chmielak Z, Klopotowski M, Kruk M, Demkow M, Konka M, Chojnowska L, et al. Repeat percutaneous mitral balloon valvuloplasty for patients with mitral valve restenosis. Catheterization and Cardiovascular Interventions 2010;76(7):986-92. https://pubmed.ncbi.nlm.nih.gov/20506140/
31
32. Gil IJN, Palacios-Rubio J, Bautista D, Salinas P, Macaya C, Fernández-Ortiz A. Long-term results of repeat percutaneous mitral valvuloplasty: Is it still a viable option? Revista Española de Cardiología 2015;68(08):728-30. https://pubmed.ncbi.nlm.nih.gov/26139556/
32
33. Pathan AZ, Mahdi NA, Leon MN, Lopez-Cuellar J, Simosa H, Block PC, et al. Is redo percutaneous mitral balloon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis? J Am Coll Cardiol 1999;34(1):49-54. https://pubmed.ncbi.nlm.nih.gov/10399991/
33
34. Bouleti C, Iung B, Himbert D, Messika-Zeitoun D, Brochet E, Garbarz E, et al. Long-term impact of repeat percutaneous mitral commissurotomy on the need for surgery in mitral stenosis. Insights from a series of 912 patients with a 20-year follow-up. Archives of Cardiovascular Diseases Supplements 2012;4(1):90-1.
34
35. Aslanabadi N, Golmohammadi A, Sohrabi B, Kazemi B. Repeat percutaneous balloon mitral valvotomy vs mitral valve replacement in patients with restenosis after previous balloon mitral valvotomy and unfavorable valve characteristics. Clin Cardiol 2011;34(6):401-6. https://pubmed.ncbi.nlm.nih.gov/21538391/
35
36. Song JK, Song JM, Kang DH, Yun SC, Park DW, Lee SW, et al. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator. Eur Heart J 2009;30(10):1254-62. https://pubmed.ncbi.nlm.nih.gov/19346230/
36
ORIGINAL_ARTICLE
Association Between Interleukin-4 Promoter and Receptor Polymorphisms and T-cell Count in Iranian HIV Positive Population
Background: Single Nucleotide Polymorphisms (SNPs) in the IL-4 promoter and receptor genes have been proposed to alter the individual’s susceptibility to HIV infection and the rate of progression to AIDS. IL-4 -589 C/T and IL-4Rα I50V polymorphisms have been studied in different populations and were linked to differences in disease progression. No study has assessed the frequency of these polymorphisms in Iranian population.Methods: In a cross-sectional study, after obtaining written informed consent, blood samples were collected from 120 HIV-seropositive individuals (91 males, 12 females) visiting a tertiary referral HIV center. All patients were primarily screened with the fourth-generation ELISA HIV test for the HIV-1 markers and subsequently with polymerase chain reaction (PCR). CD4+ cell count of the patients was recorded by using fresh EDTA-whole blood samples. The genomic DNA was extracted from peripheral blood mononuclear cells (PBMC) using the standard extraction kit. Then, PCR-RFLP technique was used to analyze IL-4 -589 C/T, and IL-4Rα I50V SNPs.Results: A frequency of 0.08 was found for IL-4 -589 T allele and 0.055 for IL-4Rα V allele. There was no significant difference between these polymorphisms regarding CD4 cell counts (p = 0.44 and p = 0.08 for IL-4 -589 and IL-4RαI50V, respectively). Conclusion: This is the first study to assess the frequency of IL-4 promoter and receptor polymorphisms in the Iranian HIV-seropositive population. No significant association was found between IL-4 promoter and receptor polymorphisms and CD4 cell counts.
http://www.jimc.ir/article_106680_1efc85ea206d3c92ac9f735644501351.pdf
2019-10-01
209
214
CD4 lymphocyte count
HIV
Interleukin-4
Polymorphism
Promoter
Kamal
Fakhredini
1
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Ali
Asadollahi-Amin
2
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Fatemeh
Ghadimi
3
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Mohammad
Gholami
4
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Omid
Dadras
omiddadras@yahoo.com
5
Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
LEAD_AUTHOR
SeyedAhmad
SeyedAlinaghi
s_a_alinaghi@yahoo.com
6
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
1. Sharifi H, Mirzazadeh A, Shokoohi M, Karamouzian M, Khajehkazemi R, Navadeh S, et al. Estimation of HIV incidence and its trend in three key populations in Iran. PLoS One 2018;13(11):e0207681. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264468/
1
2. Joulaei H, Lankarani KB, Kazerooni PA, Marzban M. Number of HIV-infected cases in Iran: True or just an iceberg. Indian J Sex Transm Dis AIDS 2017;38(2):157-62. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085928/
2
3. Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag 2017;6(2):65-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287931/
3
4. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther 2007;4(1):11. https://www.ncbi.nlm.nih.gov/pubmed/17502001
4
5. Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, et al. Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 2002;16(17):2275-84. https://pubmed.ncbi.nlm.nih.gov/12441799/
5
6. Singh S, Arora S. Impact of cytokine gene polymorphism on the HIV-1 disease progression and response to therapy. J AIDS Clin Res 2015;6:506.
6
7. Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, et al. Protective effect of interleukin-4-589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Inf Dis 2002;185(8):1183-6.
7
8. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA. Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol 2003;13(23):2118-23. https://www.ncbi.nlm.nih.gov/pubmed/14654003
8
9. Cui T, Wu J, Pan S, Xie J. Polymorphisms in the IL-4 and IL-4R [α] genes and allergic asthma. Clin Chem Lab Med 2003;41(7):888-92. https://www.ncbi.nlm.nih.gov/pubmed/12940513
9
10. Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, et al. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol 2004;138(1):145-50. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1809180/
10
11. Nakayama EE, Hoshino Y, Xin X, Liu H, Goto M, Watanabe N, et al. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol 2000;74(12):5452-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC112029/
11
12. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;25(Suppl 2):74-8; discussion 95-6. https://www.ncbi.nlm.nih.gov/pubmed/8590350
12
13. Singh P, Rajput R, Mehra NK, Vajpayee M, Sarin R. Cytokine gene polymorphisms among North Indians: Implications for genetic predisposition? Infect Genet Evol 2019;73:450-59. https://www.ncbi.nlm.nih.gov/pubmed/31173933
13
14. Chatterjee A, Rathore A, Dhole TN. Association of IL-4 589 C/T promoter and IL-4RαI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J Med Virol 2009;81(6):959-65. https://www.ncbi.nlm.nih.gov/pubmed/19382262
14
15. Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, Schuitemaker H. Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants. AIDS 2003;17(7):981-5. https://www.ncbi.nlm.nih.gov/pubmed/12700447
15
16. Wichukchinda N, Nakayama EE, Rojanawiwat A, Pathipvanich P, Auwanit W, Vongsheree S, et al. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. AIDS 2006;20(2):189-96. https://www.ncbi.nlm.nih.gov/pubmed/16511411
16
17- Baesi K, Moallemi S, Farrokhi M, Alinaghi SA, Truong HM. Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013. PLoS One 2014;9(9):e105098. https://www.ncbi.nlm.nih.gov/pubmed/25188443
17
18. Singh KK, Hughes MD, Chen J, Spector SA. Lack of protective effects of interleukin-4− 589-C/T polymorphism against HIV-1-related disease progression and central nervous system impairment, in children. J Infect Dis 2004;189(4):587-92. https://pubmed.ncbi.nlm.nih.gov/14767810/
18
19. Soriano A, Lozano F, Oliva H, García F, Nomdedéu M, De Lazzari E, et al. Polymorphisms in the interleukin-4 receptor α chain gene influence susceptibility to HIV-1 infection and its progression to AIDS. Immunogenetics 2005;57(9):644-54. https://www.ncbi.nlm.nih.gov/pubmed/16189667
19
ORIGINAL_ARTICLE
The Effects of Dry Needling As a Novel Recovery Strategy on Quadriceps Muscle Fatigue: A Pilot Study
Background: Dry Needling (DN) is a procedure to treat neuromusculoskeletal disorders. This study aimed to examine the effects of DN on quadriceps muscle fatigue in healthy young adults.Methods: Fifteen healthy young subjects (13 male, 2 female; mean±standard deviation 26.1±5.9 years) participated in a pretest-posttest study. Subjects received one session of DN for a total of 3 minutes with one minute each for the vastus medialis, vastus lateralis, and rectus femoris muscles. The Isometric Peak Torque (IPT), Single Leg Hop (SLH) test, and Y Balance Test (YBT) were measured at baseline, immediately after completion of the fatigue protocol, and after DN.Results: Repeated measures ANOVA demonstrated significant improvements in the IPT, SLH, and YBT scores after DN. Effects sizes were medium for IPT (d =0.61) and SLH test (d=0.57), and large for YBT (d=0.7).Conclusion: Dry needling had a significant effect on recovery of quadriceps muscle fatigue, functional performance, and dynamic balance. These findings suggest that DN can be utilized as a novel recovery strategy to manage muscle fatigue. Further research is warranted.
http://www.jimc.ir/article_106683_a13232bff773713e0246a8108d0db061.pdf
2019-10-01
215
221
Dry needling
Exercise
Muscle fatigue
sports
Navid
Ershad
1
Department of Physiotherapy, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Noordin
Nokhostin Ansari
nakhostin@sina.tums.ac.ir
2
Department of Physiotherapy, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Soofia
Naghdi
3
Department of Physiotherapy, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Khadijeh
Otadi
4
Department of Physiotherapy, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Elham
Gorji
5
Department of Physiotherapy, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Jan
Dommerholt
6
Bethesda Physiocare, Bethesda, MD, USA; Myopain Seminars, Bethesda, MD, USA
AUTHOR
1. Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 2001;81 (4):1725-89. . https://www.ncbi.nlm.nih.gov/pubmed/11581501
1
2. Paul L, Wood, l. Skeletal muscle fatigue. Phys Ther Rev 2002;7(2):123-32.
2
3. Wan JJ, Qin Z, Wang PY, Sun Y, Liu X. Muscle fatigue: general understanding and treatment. Exp Mol Med 2017; 49(10):e384. https://pubmed.ncbi.nlm.nih.gov/28983090/
3
4. Gribble PA, Hertel J. Effect of lower-extremity muscle fatigue on postural control. Arch Phys Med Rehabil 2004;85(4):589-92. https://www.ncbi.nlm.nih.gov/pubmed/15083434
4
5. Calleja-González J, Mielgo-Ayuso J, Sampaio J, Delextrat A, Ostojic SM, Marques-Jiménez D, et al. Brief ideas about evidence based recovery in team sports. J Exerc Rehabil 2018;14(4):545-50. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165975/
5
6. Ansari NN, Naghdi S, Karimi-Zarchi H, Fakhari Z, Hasson S. A randomized controlled pilot study to investigate the effect of whole body vibration on lower-extremity fatigue. J Sport Rehabil 2017;26(5):339-46. https://www.ncbi.nlm.nih.gov/pubmed/27632878
6
7. Dommerholt J, Fernández-de-Las-Peñas C, Petersen SM. Needling: is there a point? J Man Manip Ther 2019;27(3):125-7. https://www.ncbi.nlm.nih.gov/pubmed/31230588
7
8. Cerezo-Téllez E, Torres-Lacomba M, Mayoral-Del-Moral O, Pacheco-da-Costa S, Prieto-Merino D, Sánchez-Sánchez B. Health related quality of life improvement in chronic non-specific neck pain: secondary analysis from a single blinded, randomized clinical trial. Health Qual Life Outcomes 2018;16(1):207. https://www.ncbi.nlm.nih.gov/pubmed/30400984
8
9. Hsieh YL, Yang SA, Yang CC, Chou LW. Dry needling at myofascial trigger spots of rabbit skeletal muscles modulates the biochemicals associated with pain, inflammation, and hypoxia. Evid Based Complement Alternat Med 2012;2012:342165. https://www.ncbi.nlm.nih.gov/pubmed/23346198
9
10. Ansari NN, Naghdi S, Fakhari Z, Radinmehr H, Hasson S. Dry needling for the treatment of poststroke muscle spasticity: a prospective case report. NeuroRehabilitation 2015;36(1):61-5. https://www.ncbi.nlm.nih.gov/pubmed/25547766
10
11. Fakhari Z, Ansari NN, Naghdi S, Mansouri K, Radinmehr H. A single group, pretest-posttest clinical trial for the effects of dry needling on wrist flexors spasticity after stroke. NeuroRehabilitation 2017;40(3):325-36. https://www.ncbi.nlm.nih.gov/pubmed/28222554
11
12. Sanchez-Mila Z, Salom-Moreno J, Fernandez-de-Las- Penas C. Effects of dry needling on post-stroke spasticity, motor function and stability limits: a randomised clinical trial. Acupunct Med 2018;36(6):358-66. https://www.ncbi.nlm.nih.gov/pubmed/29986902
12
13. Haser C, Stöggl T, Kriner M, Mikoleit J, Wolfahrt B, Scherr J, et al. Effects of dry needling on thigh
13
muscle strength and hip flexion in elite soccer players. Med Sci Sports Exerc 2017;49(2):378-83. https://www.ncbi.nlm.nih.gov/pubmed/27685009
14
14. Ansari NN, Alaei P, Naghdi S, Fakhari Z, Komesh S, Dommerholt J. Immediate effects of dry needling as a novel strategy for hamstring flexibility: a single blinded clinical pilot study. J Sport Rehabil 2020;29(2):156-61. https://www.ncbi.nlm.nih.gov/pubmed/30526283
15
15. Sawle L, Freeman J, Marsden J. Intra-rater reliability of the multiple single-leg hop-stabilization test and relationships with age, leg dominance and training. Int J Sports Phys Ther 2017;12(2):190-8. https://www.ncbi.nlm.nih.gov/pubmed/28515973
16
16. Shaffer SW, Teyhen DS, Lorenson CL, Warren RL, Koreerat CM, Straseske CA, et al. Y-balance test: a reliability study involving multiple raters. Mil Med 2013;178(11):1264-70. https://www.ncbi.nlm.nih.gov/pubmed/24183777
17
17. Plisky PJ, Gorman PP, Butler RJ, Kiesel KB, Underwood FB, Elkins B. The reliability of an instrumented device for measuring components of the star excursion balance test. N Am J Sports Phys Ther 2009;4(2):92-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953327/
18
18. Bar-Or O. The Wingate anaerobic test. An update on methodology, reliability and validity Sports Med 1987;4(6):381-94. https://www.ncbi.nlm.nih.gov/pubmed/3324256
19
19. Botter A, Oprandi G, Lanfranco F, Allasia S, Maffiuletti NA, Minetto MA. Atlas of the muscle motor points for the lower limb: implications for electrical stimulation procedures and electrode positioning. Eur J Appl Physiol 2011;111(10):2461-71. https://www.ncbi.nlm.nih.gov/pubmed/21796408
20
20. Degens H, Salmons S, Jarvis JC. Intramuscular pressure, force and blood flow in rabbit tibialis anterior muscles during single and repetitive contractions. Eur J Appl Physiol Occup Physiol 1998;78(1):13-9. https://www.ncbi.nlm.nih.gov/pubmed/9660151
21
21. Taylor JL, Amann M, Duchateau J, Meeusen R, Rice CL. Neural contributions to muscle fatigue: from the brain to the muscle and back again. Med Sci Sports Exerc 2016;48(11):2294-306. https://www.ncbi.nlm.nih.gov/pubmed/27003703
22
22. Dar G, Hicks G. The immediate effect of dry needling on multifidus muscles’function in healthy individuals. J Back Musculoskelet Rehabil 2016;29(2):273-8. https://www.ncbi.nlm.nih.gov/pubmed/26406203
23
23. Gonell AC, Romero JA, Soler LM. Relationship between the balance test scores and soft tissue injury incidence in a soccer team. Int J Sports Phys Ther 2015;10(7):955-66. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675196/
24
24. Mullins JF, Nitz AJ, Hoch MC. Dry needling equilibration theory: A mechanistic explanation for enhancing sensorimotor function in individuals with chronic ankle instability. Physiother Theory Pract 2019:1-10. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/31311365
25
ORIGINAL_ARTICLE
Knowledge of Primary Eye Care among Medical Students in Iran
Background: The purpose of this study was evaluating the medical students’ knowledge of Primary Eye Care (PEC) for determining the level of Eye Care Programs (ECPs) in Iran. Methods: In this cross-sectional study, a self-administered questionnaire was applied to collect the data from 504 medical students at Mazandaran University of Medical Sciences. The participants answered a total of 60 questions in 4 sections. The knowledge of medical students about the PEC and the importance of developing the ECPs in Iran were evaluated. Chi-square and Fisher’s exact test were used to assess the association between variables.Results: The majority of the participants were under 30 years old and about half of them were undergraduate students and 49.4% were graduate students. About 54.4% of the subjects wore glasses and only 13.3% of them knew about the ECPs (p=0.028). Thirty-two and a half percent of subjects with glasses rarely had regular eye visits (at least once a year), and 42% of subjects without glasses also had blurred vision (p<0.001). Only 14.5% of contact lens wearers knew about the ECPs and 47.6% of them rarely had regular eye visits (p=0.013). About 90% of electronic device users didn’t know about the PEC and related educational programs for reducing computer vision syndrome (p=0.018).Conclusion: A considerable number of participants had weak knowledge about PEC and regular eye visits, and paid more attention to treatment than prevention. Preparation and implementation of educational ECPs are recommended to raise the level of PEC knowledge for improving eye health.
http://www.jimc.ir/article_106690_76d6c2bb5e47abcfc4f77bb40befe520.pdf
2019-10-01
222
228
Knowledge
Medical students
Primary eye care
Program
Zahra
Heidari
zahra.heidari77@yahoo.com
1
Department of Rehabilitation Science, Mazandaran University of Medical Sciences, Sari, Iran
LEAD_AUTHOR
Hasan
Siamian
siamian46@gmail.com
2
Faculty of Allied Medical Sciences, Mazandaran University of Medical Sciences, Sari, Iran
AUTHOR
1. Tavassoli M. Iranian health houses open the door to primary care. Bull World Health Organ 2008;86(8):585-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649473/
1
2. Murthy G, Raman U. Perspectives on primary eye care. Community Eye Health 2009;22(69):10-11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683556/
2
3. Reed G. Cuba’s primary health care revolution: 30 years on. Bull World Health Organ 2008;86(5):327-9. https://www.ncbi.nlm.nih.gov/pubmed/18545731
3
4. Resnikoff S, Pararajasegaram R. Blindness prevention programmes: past, present, and future. Bull World Health Organ. 2001;79(3):222-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566377/
4
5. Williams C, Szetu JL, Ramke J, Palagyi A, du Toit R, Brian, G. Evaluation of the first 5 years of a national eye health programme in Vanuatu. J Clin Exp Ophthalmol 2008;36:162-167.
5
6. World Health Organization. Global Initiative for the Elimination of Avoidable Blindness: action plan 2006-2011. Geneva: WHO; 2007.
6
7. World Health Organization. Action plan for the prevention of avoidable blindness and visual impairment 2009–2013. Geneva, Switzerland: WHO; 2010.
7
8. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82(11):844-51. https://www.ncbi.nlm.nih.gov/pubmed/15640920
8
9. Wagner-Lampl A, Oliver GW. Folklore of blindness. J Vis Impair Blind 1994;88:267-276.
9
10. World Health Organization. Action Plan for the Prevention of Avoidable Blindness and Visual Impairment 2014–2019. Geneva: Switzerland: WHO; 2013.
10
11. Lewallen S, Roberts H, Hall A, Onyange R, Temba M, Banzi J, et al. Increasing cataract surgery to meet Vision 2020 targets; experience from two rural programmes in East Africa. Br J Ophthalmol2005;89(10):1237-40. https://www.ncbi.nlm.nih.gov/pubmed/16170107
11
12. Patel I, Munoz B, Burke AG, Kayongoya A, McHiwa W, Schwarzwalder AW, et al. Impact of presbyopia on quality of life in a rural African setting. Ophthalmology 2006;113(5):728-34. https://www.ncbi.nlm.nih.gov/pubmed/16650665
12
13. Smith AF, Pitt AD, Rodruiguez AE, Alio JL, Marti N, Teus M, et al. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol 2005;12(4):233-42. https://www.ncbi.nlm.nih.gov/pubmed/16033744
13
14. Rahman ZA, Sanip S. Computer user: demographic and computer related factors that predispose user to get computer vision syndrome. International Journal of Business, Humanities and Technology 2011;1(2):84-91.
14
15. Yan Z, Hu L, Chen H, Lu F. Computer Vision Syndrome: A widely spreading but largely unknown epidemic among computer users. Comput Human Behav 2008;24(5):2026-42.
15
16. Al Rashidi SH, Alhumaidan H. Computer vision syndrome prevalence, knowledge and associated factors among Saudi Arabia University Students: Is it a serious problem? Int J Health Sci (Qassim) 2017;11(5):17-9. https://www.ncbi.nlm.nih.gov/pubmed/29114189
16
17. Amirul F, Aqilah R, Lee M, Azuhairi A, Isa M. Knowledge, attitude and practice of computer vision syndrome among staffs that use video display terminal in a faculty of a Malaysian public university. International Journal of Public Health and Clinical Sciences 2015;2(1):137-47.
17
18. Reddy SC, Low CK, Lim YP, Low LL, Mardina F, Nursaleha MP. Computer vision syndrome: a study of knowledge and practices in university students. Nepal J Ophthalmol 2013;5(2):161-168. https://www.ncbi.nlm.nih.gov/pubmed/24172549
18
19. Fotouhi A, Hashemi H, Mohammad K. Eye care utilization patterns in Tehran population: a population based cross-sectional study. BMC Ophthalmol 2006;6:4. https://www.ncbi.nlm.nih.gov/pubmed/16423308
19
20. Dineen BP, Bourne RR, Ali SM, Huq DM, Johnson G J. Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol 2003;87(7):820-8. https://www.ncbi.nlm.nih.gov/pubmed/12812875
20
21. Aleo CL, Murchison AP, Dai Y, Hark LA, Mayro EL, Collymore B, et al. Improving eye care follow-up adherence in diabetic patients with ocular abnormalities: the effectiveness of patient contracts in a free, pharmacy-based eye screening. Public Health 2015;129(7):996-9. https://www.ncbi.nlm.nih.gov/pubmed/26119987
21
22. Owsley C, Rhodes LA, McGwin G Jr., Mennemeyer ST, Bregantini M, Patel N, et al. Eye care quality and accessibility improvement in the community (EQUALITY) for adults at risk for glaucoma: study rationale and design. Int J Equity Health 2015;14:135. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652429/
22
23. Mafwiri MM, Jolley E, Hunter J, Gilbert CE, Schmidt E. Mixed methods evaluation of a primary eye care training programme for primary health workers in Morogoro Tanzania. BMC Nurs 2016;15:41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936119/
23
24. Mays DC, O’Neil EJ Jr., Mworozi EA, Lough BJ, Tabb ZJ, Whitlock AE, et al. Supporting and retaining Village Health Teams: an assessment of a community health worker program in two Ugandan districts. Int J Equity Health 2017;16:129.
24
25. Okwen M, Lewallen S, Courtright P. Primary eye care skills scores for health workers in routine and enhanced supervision settings. Public Health 2014;128(1):96-100. https://www.ncbi.nlm.nih.gov/pubmed/24359760
25
26. AbdulRahman AA, Rabiu MM, Alhassan MB. Knowledge and practice of primary eye care among primary healthcare workers in northern Nigeria. Trop Med Int Health 2015;20(6):766-72. https://www.ncbi.nlm.nih.gov/pubmed/25708905
26